302 related articles for article (PubMed ID: 31226389)
1. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.
Wilman HR; Parisinos CA; Atabaki-Pasdar N; Kelly M; Thomas EL; Neubauer S; ; Mahajan A; Hingorani AD; Patel RS; Hemingway H; Franks PW; Bell JD; Banerjee R; Yaghootkar H
J Hepatol; 2019 Sep; 71(3):594-602. PubMed ID: 31226389
[TBL] [Abstract][Full Text] [Related]
2. Associations of genetically determined iron status across the phenome: A mendelian randomization study.
Gill D; Benyamin B; Moore LSP; Monori G; Zhou A; Koskeridis F; Evangelou E; Laffan M; Walker AP; Tsilidis KK; Dehghan A; Elliott P; Hyppönen E; Tzoulaki I
PLoS Med; 2019 Jun; 16(6):e1002833. PubMed ID: 31220083
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis.
Parisinos CA; Wilman HR; Thomas EL; Kelly M; Nicholls RC; McGonigle J; Neubauer S; Hingorani AD; Patel RS; Hemingway H; Bell JD; Banerjee R; Yaghootkar H
J Hepatol; 2020 Aug; 73(2):241-251. PubMed ID: 32247823
[TBL] [Abstract][Full Text] [Related]
4. Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study.
Galesloot TE; Geurts-Moespot AJ; den Heijer M; Sweep FC; Fleming RE; Kiemeney LA; Vermeulen SH; Swinkels DW
J Med Genet; 2013 Sep; 50(9):593-8. PubMed ID: 23794717
[TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
Pilling LC; Atkins JL; Melzer D
Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
[TBL] [Abstract][Full Text] [Related]
6. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
[TBL] [Abstract][Full Text] [Related]
7. Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.
Traglia M; Girelli D; Biino G; Campostrini N; Corbella M; Sala C; Masciullo C; Viganò F; Buetti I; Pistis G; Cocca M; Camaschella C; Toniolo D
J Med Genet; 2011 Sep; 48(9):629-34. PubMed ID: 21785125
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report.
Gill D; Del Greco M F; Walker AP; Srai SKS; Laffan MA; Minelli C
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1788-1792. PubMed ID: 28684612
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
[TBL] [Abstract][Full Text] [Related]
11. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
12. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
[TBL] [Abstract][Full Text] [Related]
13. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.
Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D
JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665
[TBL] [Abstract][Full Text] [Related]
14. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
Pilling LC; Tamosauskaite J; Jones G; Wood AR; Jones L; Kuo CL; Kuchel GA; Ferrucci L; Melzer D
BMJ; 2019 Jan; 364():k5222. PubMed ID: 30651232
[TBL] [Abstract][Full Text] [Related]
15. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
Nelson JE; Brunt EM; Kowdley KV;
Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
[TBL] [Abstract][Full Text] [Related]
16. Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population.
Gan W; Guan Y; Wu Q; An P; Zhu J; Lu L; Jing L; Yu Y; Ruan S; Xie D; Makrides M; Gibson RA; Anderson GJ; Li H; Lin X; Wang F
Am J Clin Nutr; 2012 Mar; 95(3):626-32. PubMed ID: 22301935
[TBL] [Abstract][Full Text] [Related]
17. Population-based analysis of the frequency of HFE gene polymorphisms: Correlation with the susceptibility to develop hereditary hemochromatosis.
Katsarou MS; Latsi R; Papasavva M; Demertzis N; Kalogridis T; Tsatsakis AM; Spandidos DA; Drakoulis N
Mol Med Rep; 2016 Jul; 14(1):630-6. PubMed ID: 27221532
[TBL] [Abstract][Full Text] [Related]
18. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
19. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Dietary and Genetic Factors Influencing Body Iron Status and Risk of Type 2 Diabetes Within the EPIC-InterAct Study.
Meidtner K; Podmore C; Kröger J; van der Schouw YT; Bendinelli B; Agnoli C; Arriola L; Barricarte A; Boeing H; Cross AJ; Dow C; Ekblom K; Fagherazzi G; Franks PW; Gunter MJ; Huerta JM; Jakszyn P; Jenab M; Katzke VA; Key TJ; Khaw KT; Kühn T; Kyrø C; Mancini FR; Melander O; Nilsson PM; Overvad K; Palli D; Panico S; Quirós JR; Rodríguez-Barranco M; Sacerdote C; Sluijs I; Stepien M; Tjonneland A; Tumino R; Forouhi NG; Sharp SJ; Langenberg C; Schulze MB; Riboli E; Wareham NJ
Diabetes Care; 2018 Feb; 41(2):277-285. PubMed ID: 29167213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
